Synairgen Plc (SNG.L)

Trade SNG.L now with
12/1/2022 2:38:17 AM Synairgen Names Amanda Radford Independent Non-Executive Director And Chair Of Audit Committee
9/29/2022 2:44:18 AM Synairgen Plc H1 Loss Per Share 6.16p Vs Loss 16.47p Last Year
9/20/2022 5:16:52 AM Synairgen To Present 60 And 90-day Long COVID Data From Phase 3 SPRINTER Study In COVID-19 Patients At IDWeek 2022
9/7/2022 4:09:54 AM Synairgen Announces Positive Findings From SG015 Tri-al Analysis In Virally Infected COPD Patients
9/5/2022 2:49:40 AM Synairgen Plc Announces Collaboration On UNIVERSAL Trial
9/30/2021 3:48:51 AM Synairgen Appoints Theodora Harold As Independent Non-Executive Director
9/30/2021 3:02:20 AM Synairgen Plc H1 Loss Per Share 16.47p Vs Loss 3.11p Last Year
5/12/2021 2:38:56 AM Synairgen FY Loss Per Share 9.46p Vs Loss 3.55p Last Year
2/15/2021 2:34:14 AM Synairgen Begins Dosing With Inhaled Interferon Beta Product In NIH ACTIV-2 Trial
1/25/2021 7:16:51 AM Synairgen Announces Clinical Trial Agreement To Include SNG001 In ACTIV-2/A5401 Phase II/III Trial